Study to Detect and Monitor CTE in Ex-NFL Players to Kick-Off in Phoenix

PHOENIX¬† —¬†Exosome Sciences, Inc., a diagnostic subsidiary of Aethlon Medical, Inc. (Nasdaq: AEMD), has announced the initiation of an Institutional Review Board (IRB) approved protocol for a research study involving retired NFL players and a data-supported biomarker candidate to potentially detect and monitor Chronic Traumatic Encephalopathy (CTE) in living individuals. The sample collection will be […]

Read more "Study to Detect and Monitor CTE in Ex-NFL Players to Kick-Off in Phoenix"